As of Feb 16
| +0.30 / +0.54%|
The 22 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 67.50, with a high estimate of 85.00 and a low estimate of 55.00. The median estimate represents a +19.91% increase from the last price of 56.29.
The current consensus among 23 polled investment analysts is to Buy stock in Merck & Co Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.